Bovine Interferon-Alpha A (IFN-αA) is a type I interferon subtype produced primarily by plasmacytoid dendritic cells and virus-infected cells in cattle (Bos taurus), where it plays a central role in early innate antiviral defense. Upon binding to the type I interferon receptor complex (IFNAR1/IFNAR2), bovine IFN-αA activates the JAK/STAT signaling pathway, leading to induction of interferon-stimulated genes (ISGs) that inhibit viral replication, enhance antigen presentation, and promote activation of natural killer (NK) cells and adaptive immune responses. In bovine health, IFN-αA is critically involved in host responses to economically significant viral infections such as bovine viral diarrhea virus (BVDV), bovine herpesvirus-1 (IBR), bovine respiratory syncytial virus (BRSV), foot-and-mouth disease virus (FMDV), and other components of the bovine respiratory disease (BRD) complex. Altered or suppressed IFN-α responses—such as immune evasion by BVDV—can contribute to viral persistence and increased disease severity. As both a biomarker and functional mediator of antiviral immunity, bovine IFN-αA is important in vaccine evaluation, antiviral strategy development, and immunopathogenesis studies. In translational research, characterization of bovine IFN-αA supports comparative studies of type I interferon biology, viral immune evasion mechanisms, and large-animal models of respiratory and systemic viral infection relevant to both veterinary and human medicine.